POAI Nasdaq 2020 - 07 - 17

Predictive Oncology Inc.

POAI A | $1.22 -6.06% -6.45% 67K

(0.0% 1d) (-50.2% 1m) (-76.8% 1y) (0.0% 2d) (-6.5% 3d) (-26.1% 7d) (-48.36% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 4,956,681
http://www.precisiontherapeutics.com
Sec Filling | Patents | 32 employees

(US) Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.

artificial intelligence

add to watch list Paper trade email alert is off

Press-releases

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
Published: 2024-03-28 (Crawled : 22:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| Email alert Add to watchlist
business year update financial results

Predictive Oncology to Participate in Upcoming Investor Conferences
Published: 2024-02-21 (Crawled : 21:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -64.58% | O: 2.18% H: 0.27% C: -6.4%

Predictive Oncology to Participate in Upcoming San Francisco Conferences
Published: 2024-01-02 (Crawled : 12:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -60.49% | O: -1.22% H: 8.92% C: 8.46%

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -59.25% | O: 3.13% H: 0.0% C: -5.78%
business update financial results

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
Published: 2023-11-08 (Crawled : 13:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -58.73% | O: 0.95% H: 2.2% C: 2.2%
hospital cancer

Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -60.73% | O: -2.11% H: 5.25% C: -2.78%
conference report financial results

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 21:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -72.75% | O: -0.21% H: 3.36% C: 2.1%
business update financial results

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -76.32% | O: 2.19% H: 0.0% C: -6.06%
conference report financial results

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
Published: 2023-07-18 (Crawled : 12:00) - globenewswire.com
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -80.42% | O: 5.42% H: 1.71% C: -9.86%

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
Published: 2023-06-27 (Crawled : 12:00) - globenewswire.com
RVLP | $0.0282 -20.92% 64M

Manufacturing

| -95.97% | O: -1.31% H: 1.32% C: -8.8%
POAI A | $1.22 -6.06% -6.45% 67K

Health Technology

| -71.24% | O: 2.43% H: 4.1% C: 0.43%
business

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001171843-24-002005	4	2024-04-12	2024-04-05	Buy	A	3268	22534
0001171843-24-002004	4	2024-04-12	2024-04-05	Buy	A	2368	9488
0001171843-24-002003	4	2024-04-12	2024-04-05	Buy	A	3268	9117
0001171843-24-002002	4	2024-04-12	2024-04-05	Buy	A	3268	31921
0001171843-24-002001	4	2024-04-12	2024-04-05	Buy	A	2353	18661